I Derm Pharma

Manufacturing · Israel · 11-50 Employees

View Company Info for Free

Overview

Headquarters

13 Wadi El-haj St, Nazareth, Israel

Phone Number

+972 527726521

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About I Derm Pharma

I Derm Pharma is a biotechnology startup focused on developing first-in-class oral therapeutics for treating autoimmune inflammatory skin diseases, particularly psoriasis. The company addresses the limitations of existing treatment options by offering a proprietary small molecule therapy that modulates inflammation without compromising the immune system. Their innovative solution combines enhanced safety and efficacy with the convenience of oral administration, aiming to improve the quality of life for the 2-3% of the global population affected by psoriasis. I Derm Pharma's target clients include patients suffering from chronic skin conditions and healthcare providers seeking effective treatment alternatives.Explore more
Popular SearchesI Derm PharmaSIC Code 28,283NAICS Code 32,325Show more

I Derm Pharma Org Chart

SN
Israel flag for contact location.

Chief Executive Officer

PhoneEmail
YT
Israel flag for contact location.

Head of Research & Development

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is I Derm Pharma your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

I Derm Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

I Derm Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about I Derm Pharma.

Top Manufacturing Companies

Frequently Asked Questions Regarding I Derm Pharma

What is I Derm Pharma's official website?
I Derm Pharma's official website is www.idermpharma.com
What is I Derm Pharma's Revenue?
I Derm Pharma's revenue is <$5 Million
What is I Derm Pharma's SIC code?
I Derm Pharma's SIC: 28,283
What is I Derm Pharma's NAICS code?
I Derm Pharma's NAICS: 32,325
How many employees does I Derm Pharma have?
I Derm Pharma has 11-50 employees
What industry does I Derm Pharma belong to?
I Derm Pharma is in the industry of: Manufacturing, Pharmaceuticals, Business Services
How do I contact I Derm Pharma?
I Derm Pharma contact info: Phone number: +972 527726521 Website: www.idermpharma.com
What does I Derm Pharma do?

I Derm Pharma is a biotechnology startup focused on developing first-in-class oral therapeutics for treating autoimmune inflammatory skin diseases, particularly psoriasis. The company addresses the limitations of existing treatment options by offering a proprietary small molecule therapy that modulates inflammation without compromising the immune s... ystem. Their innovative solution combines enhanced safety and efficacy with the convenience of oral administration, aiming to improve the quality of life for the 2-3% of the global population affected by psoriasis. I Derm Pharma's target clients include patients suffering from chronic skin conditions and healthcare providers seeking effective treatment alternatives.Read More

Is I Derm Pharma a public company?
I Derm Pharma is private company therefore does not currently have an official ticker symbol
See more information about I Derm Pharma

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.